Reduced nitric oxide synthase in the brainstem contributes to enhanced sympathetic drive in rats with heart failure.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D015153:Blotting, Western; D001933:Brain Stem / Q000737:chemistry* / Q000201:enzymology; D004195:Disease Models, Animal; D004452:Echocardiography; D015870:Gene Expression / Q000187:drug effects / Q000235:genetics; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology*; D006439:Hemodynamics / Q000187:drug effects; D017403:In Situ Hybridization; D007276:Injections, Intraventricular; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000503:physiopathology*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis* / Q000187:drug effects / Q000235:genetics; D052248:Nitric Oxide Synthase Type I; D009638:Norepinephrine / Q000652:urine; D009929:Organ Size / Q000187:drug effects; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011921:Rats, Inbred WKY; D017552:Solitary Nucleus / Q000201:enzymology; D013564:Sympathetic Nervous System / Q000378:metabolism / Q000503:physiopathology*; D019323:omega-N-Methylarginine / Q000008:administration & dosage / Q000493:pharmacokinetics
D012333:RNA, Messenger; D019323:omega-N-Methylarginine; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; C496322:Nos1 protein, rat; D009638:Norepinephrine